Submissions

Author Guidelines

Experimental Biomedical Research publishes articles in English. Since the journal does not offer translation services, if the language of the manuscripts is not enough, the editors may refuse the manuscript or ask the author to seek language editorial services to bring the manuscript to minimum standards for the review process. If your manuscript is accepted it will be checked by our copyeditors for spelling and formal style before publication.

If you would like to submit a Review, please contact Editor-in Chief at info@experimentalbiomedicalresearch.com.

 Online Submission

The articles must be submitted by the corresponding author via the Online Submissions System. If authors encounter technical problems with online submission, they may contact with support team at info@experimentalbiomedicalresearch.com.

 Corresponding author

The corresponding author’s must do: complete submission of manuscript files; storage of the article and all related documents and giving original data when necessary; contributions of the authors and explanations of conflict of interest disclosures; approval for submission; and the final proof control.

 ORCID ID

ORCiD IDs of the corresponding author and other authors must be submitted during the registration process. This section is mandatory.

As part of our commitment to ensuring an ethical, transparent and fair peer review process, Experimental Biomedical Research is a publisher who signed ORCID open letter. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.

The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.

If you do not already have an ORCID iD please follow this link to create one.

 Author Declaration, Funding and Financial Conflicts of Interest

Authors should provide a cover letter declares: that the article submitted has not been published elsewhere and is not under review; that the submission has been approved by all co-authors and, if necessary, by the responsible authorities and the institute. The publisher will not be responsible in cases of any claims for compensation.

All authors should disclose commercial ties or consulting, stock or share interests or patent license arrangements that can be viewed as a conflict of interest in relation to the manuscript presented (Author Declaration Form & Conflict Of Interest Statement).

 Permissions

Obtaining permission form the copyright owner/ owners is obligatory for figures, tables or texts that previously published elsewhere if the authors want to add them to their manuscripts. Without this evidence, any material used in the article will be deemed to be an original product of the authors.

Units of measurement

The International System of Units (SI) is the modern form of the metric system, and is the most widely used system of measurement. Therefore, units of measurement should be presented using the International System of Units in Experimental Biomedical Research.

 Abbreviations

Abbreviations are defined at the first mention and are then used continuously. The authors should always be used standard abbreviations and generic names of the drugs. Additionally, the abbreviations presented in the Tables and Figures must be compatible with SI. If registered trademarks are used, the name and country of the manufacturer must be given in parentheses following the generic name on the first use.

 Preparation of Manuscript

 Title Page

The title page should include: manuscript title, the name(s), the affiliation(s) and address (es) of the author(s).

The corresponding author information should include the e-mail address, the 16-digit ORCID ID, telephone number(s) and full mailing address.

Disclosure of conflict of interest, funding organizations and acknowledgments of people, grants, funds, etc. should be placed in the last section on the title page.

 Abstract

Abstracts must not exceed 250 words. The abstract should describe with subheadings; Aim, Method, Results, and Conclusions. Abstracts should not be contain any unexplained abbreviations or references. It is crucial that the abstract be an accurate summary of the contents of the paper. 

 Keywords

4 to 6 keywords are sufficient which can be recommended by the "Index Medicus Subject Headings": MeSH (http://www.nlm.nih.gov/mesh/meshhome.html).

 Main Text

The main text should describe with subheadings; Introduction, Methods and Materials, Results, Discussion and Conclusions. Manuscripts should be submitted in Microsoft Office Word formats and arranged as 12-point Times New Roman for text. References to literature, figures and tables should be placed in the order of their citation in the text. The Author(s) should not use italics, bold or underlined words in the texts. Please use only generic names of drugs. 

Introduction: Introduction to a research report should provide a context for the study and specify the particular aims of the reported study. In this section, the emphasis should be on brevity, for the introduction is not meant to be a detailed review but merely a capsule summary that provides a rationale for the second and most important part which is a clear statement as to why the study was undertaken.

Metods and Materials : In this section, the researcher should clearly write the methods used. The materials section should contain the information requested when the reported results need to be expanded and elaborated. It is also important to carry out appropriate statistical tests and to state the sources of the drugs and chemicals used.

Results: In this section, the authors should clearly written information collected using the methods described to achieve the objectives of the study.

Discussion: The discussion section is critical, the information collected is evaluated in relation to the objectives of the study and the context in which the study begins, and any inconsistency between the results is explained and elaborated. 

References: It is important that the authors cite appropriate and up-to-date articles for information and comments in the text.

 Conflicts of Interest

Authors must declare all relevant interests that could be perceived as conflicting. Authors should explain why each interest may represent a conflict. If no conflicts exist, the authors should state this. Submitting authors are responsible for coauthors declaring their interests.

 References

Number references in the order they are mentioned in the text; do not alphabetize. Reference citations in the text should be identified by numbers in square brackets. In listing references (Format AMA), follow NLM Style Guide , abbreviating names of journals according to Index Medicus. Indicate each author’s family name followed by a space and initials closed up without periods. Author names should be separated with a comma, never using the conjunction “and” between entries. All authors must be listed for papers with 1 to 3 authors. For papers with more than 3 authors, only the first 3 authors must be listed, followed by et al.

For online journals or articles published online ahead of print, provide the DOI number, if possible, rather than the URL. URLs used in references will not be made hyperlinks.

Journal article

List the first three authors;

Dilek G, Calik Y, Ozkuk K. Effect of vitamin D level and polypharmacy on the risk of falls in the elderly. Exp Biomed Res. 20214 ;(2): 81-88.

 More than three authors followed by et al.

Yenigun V, Azzawri A, Acar M, et al. Alcoholic extract of Tarantula cubensis (Theranekron®) induce autophagy on gastric cancer cells. Exp Biomed Res. 2021;4(2): 89-98.  

 Chapter in a book

Luck H. Catalase. In: Bergmeyer HU, edİtor. Methods of Enzymatic Analysis. New York: Academic Press; 1971. p. 885-93.

 Online document

Doe J. Title of subordinate document. In: The dictionary of substances and their effects. Royal Society of Chemistry. [cited 2016 Dec 27]. Available from:http://www.rsc.org/dose/title of subordinate document.

 The authors are responsible for the accurate and in full presentation in accordance with the journal's style of references.

 Preparation of Figures and Tables

The figures and tables should be uploaded electronically by a separate file and should be stated consecutively in the text. Each table should have an explanatory heading, and if numerical measurements are made, the units should be added to the column header. Figures should be presented in vector image formats (Illustrator, EPS, WMF, FreeHand, CorelDraw, PowerPoint, Excel etc.) or in bitmap formats (Photoshop, TIFF, GIF, JPEG, etc.). Bitmap images should be at least 300 dpi resolution.

Supplementary Materials

Authors can submit one file of supplementary material such as audio files, video clips, or datasets. A section titled “Supplementary Material” should be included before the references list with a concise description for each supplementary material file. Authors are responsible for providing the final supplementary materials files that will be published along with the article.

English Language Editing

ETHICAL STANDARDS

Ethical Responsibilities of Authors

Experimental Biomedical Research journal will follow the Committee on Publication Ethics (COPE) guidelines on how to deal with potential acts of misconduct. For this reason, authors should protected the journal trust, the professionalism of the scientific authorship, and must refrain from misrepresenting the consequences of research that could destroy all scientific effort.

Plagiarism checking

Articles sent to Experimental Biomedical Research journal are checked for possible plagiarism by using an appropriate software (iThenticate). However, corresponding and co-authors are responsible for any fraud, intentional or unintentional malpractice.

Research involving human participants and/or animals

Experimental Biomedical Research adopt ICMJE Recommendations on Protection of Research Participants. For more information, click here!

In addition to ICMJE recommendations, we also support 3Rs principals (Replacement, Reduction and Refinement) for humans and animals usage in research. Briefly 3Rs are mentioned below, and more information can be accessed here!
Replacement: approaches which avoid or replace the use of animals
Reduction: approaches which minimise the number of animals used per experiment
Refinement: approaches which minimise animal suffering and improve welfare

All work should be done with the permission of local human subjects or animal care committees (institutional and national) and clinical trials should be registered to legislation. The official numbers from these committees must be found in the Materials and Methods section (or text describing the experimental procedures).

 1) Statement of human rights

The studies involving human participants should state that the research has been endorsed by the institutional and / or national research ethics committee and that it is conducted in accordance with the ethical standards set out in the Helsinki Declaration , and that subsequent changes are also met.

 2) Statement on the welfare of animals

If you have done experimental research on animals, authors should indicate whether the international, national and / or institutional guidelines for the care and use of the animals are followed, and whether the work has been approved by an institutional research ethics committee.

Informed consent

If manuscripts report the results of an experimental research of human subjects, all authors must fulfill the International Committee of Medical Journal Editors (ICMJE) requirements on confidentiality and informed consent from patients and study participants. Therefore;

1- Informed consent is obtained from all participants before they are included in the work.

2- Distinguishing details of the participants examined (name, date of birth, identification numbers and other information) should not be published in print, photographs and genetic profiles.

3-Where someone is deceased, please make sure that you have written permission from the family or estate.

4-If the identification features are changed to protect anonymity as in genetic profiling, the authors should assure that the changes do not distort scientific meaning.

Authors may use this Patient Consent Form, which sent to the journal if requested.

The journal reserve the right to reject manuscripts that do not comply with the above-mentioned guidelines.

Publication charges

There are no submission fees, editorial processing charges, article processing charges (APCs), page charges, colour charges or publication fees for the journal Experimental Biomedical Research.

Copyright and License Policy

     Copyright (c): Author(s)

     License-This journal is licensed under a Creative Commons Attribution 4.0 International License.

Journal articles are published under the CC BY license (https://creativecommons.org/licenses/by/4.0/ ). Authors retain the copyright and full publishing rights without restrictions and agree to make their original works completely available and free to use, copy and/or redistribute in all formats without permission, as long as the authors and the original source are properly cited.

Proofs

Accepted articles are sent as portable document format (PDF) files, along with proof by e-mail to the relevant author for approval. Corrections to PDF evidence should be limited to posting errors only, and no significant additions / deletions should be made. Authors are responsible for all statements made in their work, including changes made by the copy editor and authorized by the author concerned. Authors are strongly advised to thoroughly examine the PDF evidence and return the proofs within 3 days.

Post-publication correction/retraction process

A published version of an article may need to be modified. This can be in the form of a Correction notice or a Retraction. In this case, necessary changes will be made after careful consideration by the Chief Editor, who is also supported by the Experimental Biomedical Research Editorial Team, to ensure that they are made in accordance with the guidelines of Committee on Publication Ethics (COPE).

Any necessary changes will be permanently linked to the original article and accompanied by a post-publication notice to ensure the integrity of the scientific record and to keep readers fully informed of any necessary changes. All correction and retraction notices are free to access at the point of publication.

Correction notice

An error or omission that may affect the interpretation of the article will be published as a "Correction notice", which does not impair its scientific integrity.

All major errors are accompanied by a correction notice that provides clear details of the errors and changes made in the published version.

Any minor errors will not be accompanied by a separate correction notice. Instead a footnote will be added to the article detailing to the reader that the article has been corrected.

Retractions

A Retraction notice will be issued in the following cases:

• A major error in the analysis or methods that invalidate the results in the article.
• Research misconduct or publication misconduct due to research without required ethical approvals, fabricated data, manipulated images, plagiarism, duplicate publication.

The decision to withdraw an article will be made in accordance with COPE guidelines and will include research conducted in collaboration with the Experimental Biomedical Research Chief Editor and Editorial Team.

In cases where a decision to withdraw an article is made:

• A "retracted" watermark is added to the published version of the article.
• A separate retraction notice titled "Withdrawal: [article title]" will be posted in connection with the retracted article.
• The withdrawal statement is paginated and published in the online issue of the journal.

Archiving

This journal utilizes the LOCKSS and CLOCKSS systems to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration.

Repository policy

Published version: OA publishing, no embargo, Licence-CC BY, For all licenses, authors retain copyright and full publication rights without restriction.

Experimental Biomedical Research

E-mail: info@experimentalbiomedicalresearch.com

Completed authorship forms may be mailed to this address.

Peer Review Policy-Process

Manuscript Submission

• New submission via online system 
• Cover letter, author and co-author details, manuscript and separate files

Pre- Quality Assessment

• Plagiarism check
• Qualification in the English language editing
• Ensuring that the manuscript adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines (Experimental Biomedical Research- Submission and Publication Checklist)
• Sent back to author for approval of edits 

Peer Review

• Double-blind peer review undertaken by experts in the field (2-4 weeks). Experimental Biomedical Research uses an "EBR-Electronic Reviewer's Assessment Form" for peer review.

• Two reviewers will evaluate each manuscript on the basis of scientific rigor of the experimental design, adequacy of the data, validity of the conclusions, importance and originality of the studies, adequacy of the literature citations, clarity of the presentation, and interest to the Journal's readership. Manuscripts will be given a quality (priority) ranking by each reviewer. Those manuscripts with low priority rankings will not be accepted even though they may have been classed as generally acceptable. If reviewers differ significantly in their opinions, the decision will be based on the priority rankings and/or the opinion of an additional reviewer (arbiter). Normally, revised manuscripts are sent back to the original reviewers together with the authors' responses.

• The reviewers' comments will be held in confidence except as follows: (a) the reviewers' comments may be sent, in whole or in part, to the corresponding author; (b) after revision, each reviewer's comments will be sent, in whole or in part, to the other reviewers of the manuscript: and (c) in the event that there is a significant difference in opinion between or among the reviewers, the manuscript may be sent to an additional reviewer (arbiter) together with the comments, in whole or in part, of the other reviewers. In all cases, anonymity of the reviewers will be maintained.

Publishing

• Accepted article is sent for generating the galley proof
• Online publication of the manuscript